New Prognostic and Predictive Markers in Cancer Progression 

<br/><br/><br/>English[eng] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>MSI2||OSCC||oral cancer||musashi 2||prognosis||N-cadherin||EMT||breast cancer||new metastasis||eribulin||blood||biomarker||bladder cancer||immune checkpoint inhibitor||CD8+ T effector cells||microRNA||biomarkers||head and neck cancer||laryngeal cancer||prediction||metastasis||lifestyle habit||chemo-/radio resistance||therapeutic target||AKT||AR||castration-resistant prostate cancer (CRPC)||MAPK||mTOR||PI3K||prostate cancer||therapeutic resistance||WNT||miRNA||melanoma||melanoma resistance to MAPK/MEK inhibitors||resistance to immune checkpoint inhibitors||TNBC||BRCA1/2||HRR||PDL1||TILs||PI3KCA||PTEN||CTCs||CSC||pancreatic cancer||K-RAS oncogene||oncogene dependency||targeted therapies||genomic mutations||transcriptomics||metabolomics||selenoproteins||cancer||HUB nodes||major histocompatibility complex (MHC)||human leukocyte antigen (HLA)||antigen processing machinery (APM) molecules||carcinogenesis||tumor predisposition||cancer immunotherapy||pheochromocytoma||paraganglioma||head and neck neoplasms||head and neck tumors||genetic syndromes||mutations||hyperglycemia||cardioncology||nivolumab||cytokines||cardiotoxicity||acetyltransferase||cancer prognosis||NAA10||n/a